(Q34332607)

1 August 2017

1 reference

title

Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis (English)

1 reference

1 August 2017

1 reference

B F Cole

1

1 reference

1 August 2017

R D Gelber

2

1 reference

1 August 2017

S Gelber

3

1 reference

1 August 2017

A S Coates

4

1 reference

1 August 2017

A Goldhirsch

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

358

1 reference

1 August 2017

277-286

1 reference

1 August 2017

9278

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

Quality adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

A quality-adjusted survival meta-analysis of adjuvant chemotherapy for premenopausal breast cancer. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

Utility approach to measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

Subsets within the chemotherapy overview. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2905483-6

7 January 2021

10.1016/S0140-6736(01)05483-6

Identifiers

DOI

1 reference

1 August 2017

1 reference